[go: up one dir, main page]

AU2003261782A1 - Bacteriophages and remedies for bacterial infection - Google Patents

Bacteriophages and remedies for bacterial infection

Info

Publication number
AU2003261782A1
AU2003261782A1 AU2003261782A AU2003261782A AU2003261782A1 AU 2003261782 A1 AU2003261782 A1 AU 2003261782A1 AU 2003261782 A AU2003261782 A AU 2003261782A AU 2003261782 A AU2003261782 A AU 2003261782A AU 2003261782 A1 AU2003261782 A1 AU 2003261782A1
Authority
AU
Australia
Prior art keywords
bacteriophages
remedies
bacterial infection
bacterial
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261782A
Inventor
Shosuke Imai
Shigenobu Matsuzaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Techno Network Shikoku Co Ltd
Original Assignee
Techno Network Shikoku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techno Network Shikoku Co Ltd filed Critical Techno Network Shikoku Co Ltd
Publication of AU2003261782A1 publication Critical patent/AU2003261782A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003261782A 2002-08-28 2003-08-28 Bacteriophages and remedies for bacterial infection Abandoned AU2003261782A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-249590 2002-08-28
JP2002249590 2002-08-28
PCT/JP2003/010896 WO2004020635A1 (en) 2002-08-28 2003-08-28 Bacteriophages and remedies for bacterial infection

Publications (1)

Publication Number Publication Date
AU2003261782A1 true AU2003261782A1 (en) 2004-03-19

Family

ID=31972587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261782A Abandoned AU2003261782A1 (en) 2002-08-28 2003-08-28 Bacteriophages and remedies for bacterial infection

Country Status (3)

Country Link
JP (1) JPWO2004020635A1 (en)
AU (1) AU2003261782A1 (en)
WO (1) WO2004020635A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2037946B2 (en) * 2006-05-05 2023-11-01 Bactoclear Holdings Pte. Ltd. Phage derived antimicrobial activities
US8012730B1 (en) * 2006-08-29 2011-09-06 The United States Of America As Represented By The Secretary Of Agriculture Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
DE102006061002A1 (en) * 2006-12-22 2008-06-26 Profos Ag Method and means for enrichment, removal and detection of gram-positive bacteria
JP2010536354A (en) * 2007-08-22 2010-12-02 ヒグロス インベスト ゲーエムベーハー New proteins for use in human and animal Staphylococcus infections
CA2729160C (en) * 2008-07-03 2017-11-14 The Rockefeller University A chimeric bacteriophage lysin with activity against staphylococci bacteria
JP5732397B2 (en) 2008-10-10 2015-06-10 ルソメディカメンタ, エス.エー.Lusomedicamenta, S.A. Antibacterial phage peptides and uses thereof
CN102417896B (en) * 2011-11-25 2013-04-17 江南大学 Phage for staphylococcus aureus and application thereof
CN104805066B (en) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 A kind of staphylolytic enzyme and its application
KR102131692B1 (en) 2018-09-11 2020-07-08 경북대학교 산학협력단 Use of novel recombinant enzyme LysSAP26 killing pathogenic bacteria
CN115125216B (en) * 2022-06-27 2024-03-05 广东省人民医院 Methicillin-resistant staphylococcus aureus phage and application thereof
WO2024263589A1 (en) 2023-06-20 2024-12-26 Topaz Biosciences, Inc. Recombinant cell wall hydrolases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
US20020001590A1 (en) * 2000-04-20 2002-01-03 Mount Sinai Hospital Antibacterial therapy for multi-drug resistant bacteria

Also Published As

Publication number Publication date
WO2004020635A1 (en) 2004-03-11
JPWO2004020635A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU5982300A (en) Novel methods and medicament for treating infectious diseases involving microbial biofilms
AU2001268564A1 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
AU2003231866A1 (en) Herbs and herbal combinations useful for the treatment of microbial infections
EP1594444A3 (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
AU2003263973A1 (en) Open medical system
AU2002347458A1 (en) Device for intracorporeal and extracorporeal purification
AU2003299561A1 (en) Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2003279526A1 (en) Identifying and treating vaginal infections
AU2003292422A1 (en) Oxazolidinone derivatives and their use as antibacterial agents
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2003272902A1 (en) Remedies
AU2003261782A1 (en) Bacteriophages and remedies for bacterial infection
AU2002312778A1 (en) Type iii bacterial strains for use in medicine
AU2003210258A1 (en) Piperidine ouracil used as a medicament for treating bacterial infections
AU2003239132A1 (en) Methods and compositions for preventing and treating microbial infections
AU2002249253A1 (en) Universal antimicrobial treatment
AU2003217007A1 (en) Bacterial spores
AU2002361548A1 (en) Compositions and methods for bacteria detection
AU2002353774A1 (en) Products and methods for treating microbial infections
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2003272901A1 (en) Remedies
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
AU2002314331A1 (en) Bacteriophage preparation for the treatment of intracellular bacterial infection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase